180 related articles for article (PubMed ID: 11340570)
1. Optimization of differential photodynamic effectiveness between normal and tumor urothelial cells using 5-aminolevulinic acid-induced protoporphyrin IX as sensitizer.
Seidl J; Rauch J; Krieg RC; Appel S; Baumgartner R; Knuechel R
Int J Cancer; 2001 Jun; 92(5):671-7. PubMed ID: 11340570
[TBL] [Abstract][Full Text] [Related]
2. RNA expression profiling of normal and tumor cells following photodynamic therapy with 5-aminolevulinic acid-induced protoporphyrin IX in vitro.
Wild PJ; Krieg RC; Seidl J; Stoehr R; Reher K; Hofmann C; Louhelainen J; Rosenthal A; Hartmann A; Pilarsky C; Bosserhoff AK; Knuechel R
Mol Cancer Ther; 2005 Apr; 4(4):516-28. PubMed ID: 15827324
[TBL] [Abstract][Full Text] [Related]
3. Regulation of 5-aminolevulinic acid-mediated protoporphyrin IX accumulation in human urothelial carcinomas.
Inoue K; Karashima T; Kamada M; Shuin T; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J
Pathobiology; 2009; 76(6):303-14. PubMed ID: 19955842
[TBL] [Abstract][Full Text] [Related]
4. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells.
Steinbach P; Kriegmair M; Baumgartner R; Hofstädter F; Knüchel R
Urology; 1994 Nov; 44(5):676-81. PubMed ID: 7974943
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution of Photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: implications for photodynamic therapy.
Xiao Z; Miller GG; McCallum TJ; Brown KM; Lown JW; Tulip J; Moore RB
Photochem Photobiol; 1998 May; 67(5):573-83. PubMed ID: 9613241
[TBL] [Abstract][Full Text] [Related]
6. Cell-type specific protoporphyrin IX metabolism in human bladder cancer in vitro.
Krieg RC; Fickweiler S; Wolfbeis OS; Knuechel R
Photochem Photobiol; 2000 Aug; 72(2):226-33. PubMed ID: 10946577
[TBL] [Abstract][Full Text] [Related]
7. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
[TBL] [Abstract][Full Text] [Related]
8. Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid.
Steinbach P; Weingandt H; Baumgartner R; Kriegmair M; Hofstädter F; Knüchel R
Photochem Photobiol; 1995 Nov; 62(5):887-95. PubMed ID: 8570728
[TBL] [Abstract][Full Text] [Related]
9. Comparison of aminolevulinic acid and hexylester aminolevulinate induced protoporphyrin IX distribution in human bladder cancer.
Marti A; Jichlinski P; Lange N; Ballini JP; Guillou L; Leisinger HJ; Kucera P
J Urol; 2003 Aug; 170(2 Pt 1):428-32. PubMed ID: 12853792
[TBL] [Abstract][Full Text] [Related]
10. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin.
Iinuma S; Farshi SS; Ortel B; Hasan T
Br J Cancer; 1994 Jul; 70(1):21-8. PubMed ID: 8018536
[TBL] [Abstract][Full Text] [Related]
11. Aminolevulinic acid for photodynamic therapy of bladder carcinoma cells.
Bachor R; Reich E; Rück A; Hautmann R
Urol Res; 1996; 24(5):285-9. PubMed ID: 8931293
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of protoporphyrin IX production, phototoxicity and cell death pathway induced by hexylester of 5-aminolevulinic acid in Reh and HPB-ALL cells.
Luksiene Z; Eggen I; Moan J; Nesland JM; Peng Q
Cancer Lett; 2001 Aug; 169(1):33-9. PubMed ID: 11410323
[TBL] [Abstract][Full Text] [Related]
13. 5-Aminolevulinic acid-mediated photodynamic therapy for bladder cancer.
Inoue K
Int J Urol; 2017 Feb; 24(2):97-101. PubMed ID: 28191719
[TBL] [Abstract][Full Text] [Related]
14. Relation between intracellular location and photodynamic efficacy of 5-aminolevulinic acid-induced protoporphyrin IX in vitro. Comparison between human glioblastoma cells and other cancer cell lines.
Sailer R; Strauss WS; Wagner M; Emmert H; Schneckenburger H
Photochem Photobiol Sci; 2007 Feb; 6(2):145-51. PubMed ID: 17277837
[TBL] [Abstract][Full Text] [Related]
15. Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells.
Cosserat-Gerardin I; Bezdetnaya L; Notter D; Vigneron C; Guillemin F
J Photochem Photobiol B; 2000 Dec; 59(1-3):72-9. PubMed ID: 11332893
[TBL] [Abstract][Full Text] [Related]
16. Biosensor device for the photo-specific detection of immuno-captured bladder cancer cells using hexaminolevulinate: An ex-vivo study.
Chan KM; Vasilev K; Shirazi HS; McNicholas K; Li J; Gleadle J; MacGregor M
Photodiagnosis Photodyn Ther; 2019 Dec; 28():238-247. PubMed ID: 31394301
[TBL] [Abstract][Full Text] [Related]
17. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
18. Hexyl-aminolevulinate-mediated photodynamic therapy: how to spare normal urothelium. An in vitro approach.
Vaucher L; Jichlinski P; Lange N; Ritter-Schenk C; van den Bergh H; Kucera P
Lasers Surg Med; 2007 Jan; 39(1):67-75. PubMed ID: 17096415
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic acid-induced protoporphyrin-IX accumulation and associated phototoxicity in macrophages and oral cancer cell lines.
Sharma S; Jajoo A; Dube A
J Photochem Photobiol B; 2007 Sep; 88(2-3):156-62. PubMed ID: 17761434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
